Monitoring the official websites of global health authorities to follow safety warnings related to medicines, reviewing safety applications submitted by marketing authorization holders, conducting benefit/risk assessments based on these data, and implementing the necessary measures to minimize risks for licensed medicines or those under license application in our country.
Reviewing Risk Management Plans (RMPs) and Periodic Benefit-Risk Evaluation Reports (PBRERs) and taking the necessary measures.
Creating the list of medicines subject to additional monitoring.
Publishing Direct Healthcare Professional Communications (DHPCs).
Reviewing Risk Management Plans (RMPs) and Periodic Benefit-Risk Evaluation Reports (PBRERs) and taking the necessary measures.
Creating the list of medicines subject to additional monitoring.
Publishing Direct Healthcare Professional Communications (DHPCs).
Taking necessary measures to encourage spontaneous reporting by healthcare professionalsto ensure the effective operation of the Pharmacovigilance system.
Organizing training programs on pharmacovigilance for healthcare professionals.
Informing marketing authorization holders and relevant international organizations about the measures taken.
Working in coordination with Scientific Advisory Boards when necessary and ensuring cooperation and coordination with other departments.


